BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14592838)

  • 1. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation.
    Chiocchetti A; Indelicato M; Bensi T; Mesturini R; Giordano M; Sametti S; Castelli L; Bottarel F; Mazzarino MC; Garbarini L; Giacopelli F; Valesini G; Santoro C; Dianzani I; Ramenghi U; Dianzani U
    Blood; 2004 Feb; 103(4):1376-82. PubMed ID: 14592838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.
    Clementi R; Chiocchetti A; Cappellano G; Cerutti E; Ferretti M; Orilieri E; Dianzani I; Ferrarini M; Bregni M; Danesino C; Bozzi V; Putti MC; Cerutti F; Cometa A; Locatelli F; Maccario R; Ramenghi U; Dianzani U
    Blood; 2006 Nov; 108(9):3079-84. PubMed ID: 16720836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.
    Boggio E; Clemente N; Mondino A; Cappellano G; Orilieri E; Gigliotti CL; Toth E; Ramenghi U; Dianzani U; Chiocchetti A
    Blood; 2014 Feb; 123(8):1178-86. PubMed ID: 24363402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
    Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression.
    Chiocchetti A; Comi C; Indelicato M; Castelli L; Mesturini R; Bensi T; Mazzarino MC; Giordano M; D'Alfonso S; Momigliano-Richiardi P; Liguori M; Zorzon M; Amoroso A; Trojano M; Monaco F; Leone M; Magnani C; Dianzani U
    J Neuroimmunol; 2005 Jun; 163(1-2):172-8. PubMed ID: 15885319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
    Ramenghi U; Bonissoni S; Migliaretti G; DeFranco S; Bottarel F; Gambaruto C; DiFranco D; Priori R; Conti F; Dianzani I; Valesini G; Merletti F; Dianzani U
    Blood; 2000 May; 95(10):3176-82. PubMed ID: 10807785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
    Dianzani U; Bragardo M; DiFranco D; Alliaudi C; Scagni P; Buonfiglio D; Redoglia V; Bonissoni S; Correra A; Dianzani I; Ramenghi U
    Blood; 1997 Apr; 89(8):2871-9. PubMed ID: 9108407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
    Rieux-Laucat F; Blachère S; Danielan S; De Villartay JP; Oleastro M; Solary E; Bader-Meunier B; Arkwright P; Pondaré C; Bernaudin F; Chapel H; Nielsen S; Berrah M; Fischer A; Le Deist F
    Blood; 1999 Oct; 94(8):2575-82. PubMed ID: 10515860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
    Bettinardi A; Brugnoni D; Quiròs-Roldan E; Malagoli A; La Grutta S; Correra A; Notarangelo LD
    Blood; 1997 Feb; 89(3):902-9. PubMed ID: 9028321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inherited defects decreasing Fas function in autoimmunity.
    Dianzani U; Chiocchetti A; Ramenghi U
    Life Sci; 2003 May; 72(25):2803-24. PubMed ID: 12697265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
    Infante AJ; Britton HA; DeNapoli T; Middelton LA; Lenardo MJ; Jackson CE; Wang J; Fleisher T; Straus SE; Puck JM
    J Pediatr; 1998 Nov; 133(5):629-33. PubMed ID: 9821419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
    Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients.
    Campagnoli MF; Garbarini L; Quarello P; Garelli E; Carando A; Baravalle V; Doria A; Biava A; Chiocchetti A; Rosolen A; Dufour C; Dianzani U; Ramenghi U
    Haematologica; 2006 Apr; 91(4):538-41. PubMed ID: 16537120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
    Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
    Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
    Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
    BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
    Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.
    Aricò M; Boggio E; Cetica V; Melensi M; Orilieri E; Clemente N; Cappellano G; Buttini S; Soluri MF; Comi C; Dufour C; Pende D; Dianzani I; Ellis SR; Pagliano S; Marcenaro S; Ramenghi U; Chiocchetti A; Dianzani U
    PLoS One; 2013; 8(7):e68045. PubMed ID: 23840885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.